Cargando…

Effect of Psychological Intervention on Differentiated Thyroid Cancer Patients in the Treatment with Radioactive Iodine

OBJECTIVE: This study aimed to design a standard method of psychological intervention and evaluate the effect of such psychological intervention against the psychological distress of differentiated thyroid cancer (DTC) patients in the treatment with radioactive iodine. METHODS: The enrolled patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yan-Bin, Zuo, Li-Juan, Liu, Ya-Chao, Li, Yan-Ping, Xin, Yun-Chao, Zhang, Hong-Yan, Hou, Li-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032163/ https://www.ncbi.nlm.nih.gov/pubmed/36970302 http://dx.doi.org/10.2147/PPA.S400832

Ejemplares similares

Identification of Radioactive Iodine Refractory Differentiated Thyroid Cancer
por: Mu, Zhuan-Zhuan, et al.
Publicado: (2019)

Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis
por: Wang, Chen, et al.
Publicado: (2017)

Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
por: Liu, Jierui, et al.
Publicado: (2019)

The effect of radioactive iodine treatment for differentiated thyroid cancer on male gonadal function: a meta-analysis
por: Cai, Yanling, et al.
Publicado: (2023)

Dynamic Immune Function Changes Before and After the First Radioactive Iodine Therapy After Total Resection of Differentiated Thyroid Carcinoma
por: Shi, Zhi-Yong, et al.
Publicado: (2022)

Radioactive Iodine Therapy of Differentiated Thyroid Carcinoma: Redesigning the Paradigm
por: Goldsmith, Stanley J.
Publicado: (2017)

Low Iodine Diet for Preparation for Radioactive Iodine Therapy in Differentiated Thyroid Carcinoma in Korea
por: Chung, Jae Hoon
Publicado: (2013)

Changes in Gut Microbiota and Metabolites in Papillary Thyroid Carcinoma Patients Following Radioactive Iodine Therapy
por: Li, Wanting, et al.
Publicado: (2023)

Psychological and behavioral intervention improves the quality of life and mental health of patients suffering from differentiated thyroid cancer treated with postoperative radioactive iodine-131
por: Wu, Hong-Xia, et al.
Publicado: (2016)

Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer
por: McFarland, Daniel C, et al.
Publicado: (2014)

Radiotheragnostics Paradigm for Radioactive Iodine (Iodide) Management of  Differentiated Thyroid Cancer
por: Slonimsky, Einat, et al.
Publicado: (2020)

Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation
por: Schmidt, Angelica, et al.
Publicado: (2017)

RECIST 1.1 and serum thyroglobulin measurements in the evaluation of responses to sorafenib in patients with radioactive iodine-refractory differentiated thyroid carcinoma
por: RUAN, MAOMEI, et al.
Publicado: (2013)

Differential distribution and prognostic value of CD4(+) T cell subsets before and after radioactive iodine therapy in differentiated thyroid cancer with varied curative outcomes
por: Shi, Zhi-Yong, et al.
Publicado: (2022)

Patient Benefit-Risk Tradeoffs for Radioactive Iodine-Refractory Differentiated Thyroid Cancer Treatments
por: Mohamed, Ateesha F., et al.
Publicado: (2015)

SAT520 Efficacy of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers
por: Toro-Tobon, David, et al.
Publicado: (2023)

A New Dynamic Response to Therapy Assessment in Postoperative Patients With Low-Risk Differentiated Thyroid Cancer Treated Without Radioactive Iodine
por: Dong, Ping, et al.
Publicado: (2021)

Health state utility valuation in radioactive iodine-refractory differentiated thyroid cancer
por: Fordham, Beth A, et al.
Publicado: (2015)

The efficacy of radioactive iodine for the treatment of well-differentiated thyroid cancer with distant metastasis
por: Lin, Jen-Der, et al.
Publicado: (2018)

ODP532 Fractionated Radioactive Iodine Therapy in Management of Differentiated Thyroid Cancer
por: Khan, Adeel Ahmad, et al.
Publicado: (2022)

Influence of the first radioactive iodine ablation on peripheral complete blood count in patients with differentiated thyroid cancer
por: Hu, Tianpeng, et al.
Publicado: (2016)

Development and validation of the information needs questionnaire for differentiated thyroid cancer patient with radioactive iodine therapy (INQ‐DTC)
por: Zhang, Jing, et al.
Publicado: (2021)

Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer
por: Fullmer, Tanner, et al.
Publicado: (2021)

Radioactive Iodine-125 in Tumor Therapy: Advances and Future Directions
por: Wei, Shuhua, et al.
Publicado: (2021)

Radioactive Iodine Administration Is Associated with Persistent Related Symptoms in Patients with Differentiated Thyroid Cancer
por: Florenzano, Pablo, et al.
Publicado: (2016)

Early Sialadenitis After Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Prevalence and Predictors
por: Riachy, Ruba, et al.
Publicado: (2020)

The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER
por: Tang, Jianing, et al.
Publicado: (2018)

Radioactive Iodine Therapy Decreases Recurrence in Thyroid Papillary Microcarcinoma
por: Creach, Kimberly M., et al.
Publicado: (2012)

Radioactive Iodine Resistant Papillary Thyroid Cancer “Redifferentiated” With Dabrafenib
por: Zayouna, Christine, et al.
Publicado: (2021)

Radioactive iodine in low- to intermediate-risk papillary thyroid cancer
por: Zhao, Hengqiang, et al.
Publicado: (2022)

The benefits of radioactive iodine ablation for patients with intermediate-risk papillary thyroid cancer
por: Wang, Xiaofei, et al.
Publicado: (2020)

Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer
por: Liu, Lina, et al.
Publicado: (2022)

Effects of thyroid hormone withdrawal on metabolic and cardiovascular parameters during radioactive iodine therapy in differentiated thyroid cancer
por: An, Jee Hyun, et al.
Publicado: (2016)

Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic
por: Qiao, Tingting, et al.
Publicado: (2022)

Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients
por: Mei, Xiaoran, et al.
Publicado: (2021)

Assessment of Long-Term Hematologic Effects in Differentiated Thyroid Cancer Patients Treated with Radioactive Iodine
por: Sönmez, Bircan, et al.
Publicado: (2021)

Association of the Cumulative Dose of Radioactive Iodine Therapy With Overall Survival in Patients With Differentiated Thyroid Cancer and Pulmonary Metastases
por: Yang, Jing, et al.
Publicado: (2019)

Mindfulness-based stress reduction in patients with differentiated thyroid cancer receiving radioactive iodine therapy: a randomized controlled trial
por: Liu, Tianji, et al.
Publicado: (2019)

Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine–Refractory Differentiated Thyroid Cancer: The REALITY Randomized Clinical Trial
por: Lin, Yansong, et al.
Publicado: (2021)

Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome
por: Lukovic, Jelena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ig4vi0k6tdqlsqcblc062og1o6